5.19
price up icon0.00%   0.00
after-market Handel nachbörslich: 5.10 -0.09 -1.73%
loading

Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
13.74%
17.99
15.82 21.07 17.97 12.24
Depreciation and Amortization
10.53%
0.017
0.019 0.10 0.14 0.143
Operating Income/Loss
13.74%
-17.99
-15.82 -21.07 -17.97 -12.24
Income/Loss From Continuing Operations Before Tax
10.22%
-15.72
-14.26 -19.88 -16.63 -10.48
Income/Loss From Continuing Operations After Tax
10.22%
-15.72
-14.26 -19.88 -16.63 -10.48
Net Income/Loss
10.22%
-15.72
-14.26 -19.88 -16.63 -10.48
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
94.58%
9.15
168.78 138.28 138.24 137.59
Basic Earnings Per Share
0.00%
-0.08
-0.08 -0.14 -0.12 -0.08
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):